TIETOJA TÄSTÄ JAKSOSTA
Professor Neil Gross from MD Anderson talks us through his absolutely seminal work in the field of cutaneous SCCs and what this looks like for the head and neck community. Cemiplimab, EMPOWER, C-POST, neaodjuvant strategies - something for all the family.
Englanti
Yhdysvallat
TRANSKRIPTIO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
HAE EDELLISIÄ EPISODEJA
Hae kanavan Deep Margin vanhoja jaksoja.
MUITA jaksoja TÄSSÄ PODCASTISSA
The Danish Head and Neck Cancer (DAHANCA) group was established in 1976 as a working group by the Danish Society for Head and Neck Oncology. Since it has gone from strength to strength and continues to pioneer cooperative group research on a national scale! Current head Jeppe Friborg talks us throu…
![Episode 14 [PART 2]: Chris Holsinger, the robot, E3311; the definitive piece](https://cdn-images-3.listennotes.com/podcasts/deep-margin-tXh4kjx0dYz-6YaA5PXrmkq.1400x1400.jpg)
We're back with Chris Holsinger for part 2 of the TORS adventure
Pierre Blanchard, Professor at Gustave Roussy and Editor of Radiotherapy and Oncology 'the green journal' joins us to discuss his recent trial
Professor and Vice-chair of Hematology and Medical Oncology, and Professor of Otolaryngology at the Winship Cancer Institute at the Emory University School of Medicine in Atlanta, Georgia. He talks us through sinonasal histologies . Ben refers Will to social services.
Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin Dr Ben O'Leary and Dr Will Ince:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.
MUOKKAA
Kiitos, kun autoit pitämään podcast-tietokantaa ajan tasalla.
